# Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation

> **NCT06001593** · PHASE1,PHASE2 · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Meniere's Disease

## Interventions

- **DEVICE:** YPS-201b
- **DRUG:** betahistine
- **DEVICE:** YPS-201b

## Key facts

- **NCT ID:** NCT06001593
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-18
- **Primary completion:** 2025-11
- **Final completion:** 2025-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06001593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06001593, "Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06001593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*